EuclidSR Partners
North America, New York, United States, New York
Description
Successful venture investing combines two essential components: finding opportunities with significant growth potential and helping to
Investor Profile
EuclidSR Partners has made 19 investments, with 0 in the past 12 months and 21% as lead.
Stage Focus
- Series C (26%)
- Series B (16%)
- Series Unknown (16%)
- Series E (16%)
- Series D (11%)
- Private Equity (5%)
- Post Ipo Equity (5%)
- Series A (5%)
Country Focus
- United States (95%)
- United Kingdom (5%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Life Science
- Genetics
- Business Intelligence
- Information Technology
- Emergency Medicine
- Medical
- 3d Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
